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Three elderly ladies presented with clinical suspicion of breast cancer. Lumpectomy was performed in all 3 cases and 
histopathological examination came back as lymphocytic mastopathy. Only one of them had a classical long history of diabetes 
to suggest diabetic mastopathy. The other two cases was non-diabetic and not associated with autoimmune disease. 
Clinicopathologic and imaging revisited. The disease posed a diagnostic challenges and management dilemma.  
 




Diabetic mastopathy is a rare benign fibro-inflammatory 
disease typically found in premenopausal lady with type I 
diabetes mellitus and poor diabetic control. It is also found 
in a poorly controlled, long standing type II diabetic 
mellitus. Commonly it is associated with micro and 
macrovascular complications such as diabetic nephropathy 
or diabetic retinopathy. Other synonyms are sclerosing 
lymphocytic lobulitis or lymphocytic mastopathy. The 
clinical sign and features may mimic breast carcinoma and 
thus posed a diagnostic challenges to surgeons. Despite of 
its benign potential, the recurrence rate can be high 
especially in poorly controlled diabetes.Thus, a good review 




A 60 year-old lady presented with a hard and irregular left 
retroareolar breast lump for 6 weeks with no risk factor for 
malignancy. On Mammogram and Ultrasound axilla, it was 
reported as a BIRADS 4breast lesion with no axillary 
lymphadenopathy. An ultrasound-guided biopsy showed 
benign fibro-collagenous tissue with mild chronic 
inflammation. Because of clinical suspicion of malignancy, it 
was proceeded with an excision biopsy and the 




A 65 year-old lady presented with a 6 months history of a 
left breast lump. She had a long standing type II diabetes 
mellitus, hypertension and dyslipidemia since 2007.She was 
on both insulin and two oral hypoglycemic agents. The 
HbA1c range from 6.1 to 9%. Despite that, she developed 
diabetic retinopathy since 2016. She had a strong family 
history of diabetes. Otherwise, she has no risk factor for 
malignancy.  
Mammogram showed an irregular dense mass occupying 
the left upper mid to outer quadrant with architectural 
distortion. No suspicious group of microcalcification. On 
ultrasound, it was an irregular hypoechoic mass with 
posterior shadowing measuring 3.6 x 2.0 x 4.7cm. Minimal 
peripheral vascularity seen with adjacent architectural 
distortion. Left axillary nodes was classified as suspicious 
because of thick cortex measuring 0.4cm. Ultrasound 
guided biopsy reported as lymphocytic mastopathy. But in 
view of discordant finding and need to rule out malignancy 
in this lady, excision biopsy done. Histopathology report 
came back as diabetic mastopathy.  
 
Patient 3 
A 51 years old lady presented with painful right breast lump 
for 2 weeks with no history of trauma and no risk factor for 
malignancy. Mammogram showed no obvious abnormal 
density or calcification. Ultrasound showed ill-defined 
lesion at 10 o clock 5cm from nipple measuring 0.9 x 2.1 x 
2.7cm. No abnormal looking axillary nodes seen. Guided 
core biopsy came back as inflammatory tissue. Excision 
biopsy performed and histology report was lymphocytic 
mastopathy.  
 
Figure 1: Mammogram imaging of patient 1 showing irregular 
density at upper half of left breast. 
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Figure 2: USG feature showed irregular hypoechoic mass with 
posterior shadowing. (Patient 1) 
 
 
Figure 3: Lymphocytic mastitis characterized by keloid-like 
fibrosis and prominent lymphocytic (refer Patient 1) 
 
Discussion 
Lymphocytic mastopathy was first described as diabetic 
mastopathy, as early as 1984 by Soler and Khardori. It was 
described as a dense fibrous stromal proliferation of the 
breast in women typically in premenopausal lady with 
longstanding type I diabetes mellitus (DM)1. It represent 
less than 1% of all benign breast disease. It also can occur in 
poor diabetic control in type II diabetes mellitus. Diabetic 
microvascular end organ complication is commonly 
associated. It mostly affects women, but has also been 
reported in men.2,3Only a small percentage been reported 
in non-diabetic patient (0.13%) and some co-exist with 
autoimmune disease (0.02%) e.g Hashimoto’s thyroiditis, 
Grave’s disease, pernicious anemia, rheumatoid arthritis. 2,5 
The term ‘diabetic mastopathy’ is referred to those with 
underlying diabetes mellitus. Collectively, it is known as 
lymphocytic mastopathy in patients without diabetes, thus 
probably explained the possibility of autoimmune 
component in its pathology. They also observed a possible 
link with thyroiditis and autoimmune disease.5,8 The exact 
etiopathogensis is unknown. The postulation theory behind 
this basically the advanced glycosylated end products 
formed in long standing hyperglycemia state act as 
neoantigen and trigger an autoimmune response with B cell 
proliferation, autoantibody production, the cytokine release 
that lead to matrix expansion and stromal proliferation.7,8 
All of our patients are postmenopausal lady, age more 
than 50 years old. Only the second patient had strong risk 
factor which are the long standing history type II diabetes 
mellitus and diabetic retinopathy with poor glycemic 
control as evidence of her HbA1c persistently more than 
6%. The other two patients have no association with 
diabetic or autoimmune disease. One case have been 
reported with vitiligo with no other sign to suggest 
autoimmune disease which is slightly similar to our two 
patients.9 Any female, age more than 50 years old 
presented with hard, palpable breast lump with radiological 
suspicion of malignancy (Birad’s 5), thus breast carcinoma 
need to be considered. On mammogram, lymphocytic 
mastopathy may appear as an ill-defined mass or 
asymmetric density without associated calcifications or 
spiculations very often found in a dense breast4.4,5 
On ultrasonography, lymphocytic mastopathy classically 
appears as an irregular, poorly defined hypoechoicmass 
usually between 2 and 6 cm in size, with moderate to 
marked posterior shadowing and absence of vascularity on 
colour Doppler imaging.4,5 For all 3 patients, only second 
patient’s ultrasound guided core biopsy showed 
lymphocytic mastitis. The first patient’s core biopsy only 
showed benign fibrous tissue while the third patient was 
suggestive of an inflammatory tissue. False negative rate for 
cytology is 3-5%.2Core biopsy is essential for diagnosis to 
demonstrate the dense fibrosis and perivascular 
lymphocyte infiltrate.5,7However, in reality usually it is a 
postoperative diagnosis. Thus, the confirmatory diagnosis is 
through histopathological examination needed to 
differentiate diabetic mastopathy and malignancy.7 
The histopathological diagnosis of lymphocytis mastitis 
is well documented. The pathologic constellation are (1) 
lymphocytic lobulitis and ductitis, (2) glandular atrophy, (3) 
lymphocytic/mononuclear perivascular inflammation (4) 
dense often keloid-like fibrosis, and (5) epithelioid-like 
fibroblasts.2,3  In diabetes mastopathy, the perivascular/ 
perilobular inflammation is more predominant of B cell but 
in lymphocytic mastitis, it is predominantly T cell.2,3Other 
than that, in diabetic mastopathy it has more pronounced 
stromal fibrosis, lobular atrophy and epitheloid 
myofibroblast.2 
To date, diabetic mastopathy is a rare, self-limiting 
fibro-inflammatory breast disease as a benign entity with 
no malignant potential.2,3,6  On review, the recurrence rate 
after surgery is quite high, about 32% especially in type I 
diabetes mellitus.3Possible explanation of recurrence 
usually the surrounding tissue fibrosis in previous area can 
trigger an autoimmune response as acute in chronic 
inflammation based on the etiopathogenesis theory 
discussed earlier7,8. There is also a possibility of a new 
lesion at the contralateral of different quadrant of breast. A 
10 year retrospective study on diabetic mastopathy in type I 
diabetes mellitus have proved that the clinical and imaging 
findings are inconclusive and these lesions are often 
misdiagnosed as breast carcinomas.10More studies need to 
be done to understand more of its etiopathogenesis in the 
emerging trend of higher prevalence and incidence of 
diabetes mellitus in Malaysia. 
 
Summary  
Lymphocytic mastopathy is a diagnostic challenges and a 
masquerade of malignancy. Thus, the recognition of rare 
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